Skip to content
Screener

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$87.63B-7.4%
Amgen logo
AmgenAMGN
$95.64B+8.8%
WHW
Whitehawk TherapeuticsWHWK
$127.23M-45.6%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$137.68M-11.4%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$435.79M+58.9%
Eikon Therapeutics, Inc. logo
Eikon Therapeutics, Inc.EIKN
$850.83M

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.49B+68.5%
Enterprise value$3.36B+69.4%
P/S15×+10.3×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:05 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206357
Line itemMarch 31, 2026December 31, 2025
Long-term marketable securities301,713410,297
Property and equipment, net8,6348,217
Right-of-use assets22,61323,068
Total assets$1,030,348$1,109,324
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable$20,736$17,584
Accrued liabilities43,74540,892

Item 1. Financial Statements (UNAUDITED).

FAQ

What is IDEAYA Biosciences, Inc.'s total assets?
IDEAYA Biosciences, Inc. (IDYA) reported total assets of $1.03B in Q1 2026.
How has IDEAYA Biosciences, Inc.'s total assets changed year-over-year?
IDEAYA Biosciences, Inc.'s total assets decreased by 6.4% year-over-year, from $1.1B to $1.03B.
What is the long-term trend for IDEAYA Biosciences, Inc.'s total assets?
Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s total assets has grown at a 30.0% compound annual growth rate (CAGR), from $298.27M to $1.11B.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Ask your AI about IDEAYA Biosciences, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude